These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5069487)

  • 1. [Clinical evaluation of a new synthetic preparation (zolimidine) in the treatment of gastroduodenal diseases].
    Rivero Fontán JL; Barranco Jiménez M; Gómez Parra M
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):103-26. PubMed ID: 5069487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on 20 gastroduodenal ulcer patients treated with 2-p-methyl sulphonylphenyl imidazol (1,2-alpha) pyridine (zolimidine)].
    García Alvarez M; Ramírez Armengol JA
    Rev Clin Esp; 1972 Aug; 126(4):353-6. PubMed ID: 4638610
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic fate of Zolimidine. I. Studies in rats with the 14-C-labelled molecule.
    Almirante L; Picco S; Bonaldi A; Cattaneo R
    Farmaco Sci; 1974 Nov; 29(11):841-7. PubMed ID: 4442572
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic fate of Zolimidine. II. Analytical profile, tissue levels and urinary excretion in animals and in man.
    Picco S; Bonaldi A; Frigerio A; Danieli B; Almirante L
    Farmaco Sci; 1974 Nov; 29(11):848-60. PubMed ID: 4442573
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a new drug in the treatment of gastroduodenal diseases].
    Bagliani A; Borri P
    Minerva Gastroenterol; 1972; 18(3):165-74. PubMed ID: 4614114
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastro-protective drug, zolimidine.
    Camarri E; Zaccherotti L; D'Alonzo D
    Arzneimittelforschung; 1972 Apr; 22(4):768-72. PubMed ID: 5068258
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastropathy caused by indomethacin and gastric protection with zolimidine. Physiopathogenetic interpretations and preliminary clinical notes].
    Sovera A; Volta A
    Minerva Gastroenterol; 1974; 20(4):160-7. PubMed ID: 4459732
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C
    Clin Ter; 1979 Mar; 88(6):605-19. PubMed ID: 157245
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental clinical study of the effectiveness of glycopeptide in gastroduodenal pathology].
    Vera Camba M; Villalgordo Aparicio C; Güemes Díaz F; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1974 Mar; 43(2):225-34. PubMed ID: 4840489
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined antigastrin therapy in gastroduodenal diseases with CR 242 B (proglumide-buscapine)].
    La Banda Sañchez F
    Rev Esp Enferm Apar Dig; 1972 Jan; 36(2):231-40. PubMed ID: 5009968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Zolimidine. Evaluation of the symptomatic effect in patients with gastroduodenal diseases].
    Rizzi B; Giacomini F; Bandini V
    Minerva Gastroenterol; 1975; 21(4):258-65. PubMed ID: 778658
    [No Abstract]   [Full Text] [Related]  

  • 12. [Trial of a new drug in the treatment of gastroduodenal ulcer and gastrointestinal disorders].
    Bogazzi G; Fusco E
    Minerva Gastroenterol; 1968; 14(4):258-64. PubMed ID: 5745806
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proglumide in peptic ulcer and in gastroduodenal pathology. Clinical, biological and endoscopic study].
    Bennani A
    Med Chir Dig; 1979; 8(4):351-6. PubMed ID: 502629
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of sultroponium in gastroduodenal pathology. Clinical and biological study].
    Ribet A; Frexinos J
    Therapeutique; 1970 May; 46(5):511-3. PubMed ID: 5430223
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of sulpiride in digestive pathology].
    Négret JP
    Bord Med; 1970 Jun; 3(6):1713-8. PubMed ID: 5433898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-secretory therapy of peptic ulcer with cimetidine and activation of the mucosal barrier with zolimidine: preliminary results of combined treatment].
    Assisi R; De Miranda B; De Stefano S
    Clin Ter; 1980 Jun; 93(5):563-75. PubMed ID: 6448726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of a new synthetic anticholinergic: 1290 CERM].
    Herne N; Parneix Y
    Mars Med; 1969; 106(7):628-30. PubMed ID: 5399370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution of sulpiride in the surgery of gastroduodenal ulcer].
    René L
    Therapeutique; 1970 May; 46(5):583-4. PubMed ID: 5430235
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect, on gastric absorption, of a new molecule with mucopoietic activity, 2-)p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine, used in therapy of gastroduodenal diseases].
    Barlattani M
    Clin Ter; 1971 Dec; 59(5):417-30. PubMed ID: 5159600
    [No Abstract]   [Full Text] [Related]  

  • 20. [Univocal treatment of multiform disorders: dogmatil in psycho-digestive pathology].
    Bernard J
    Therapeutique; 1970 Mar; 46(3):336-7. PubMed ID: 5422205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.